Program
Cyclosporine
Also written as “cyclosporine”, “Cyclosporine A” and “Ciclosporin”.
Its studies are mostly in Dry Eye Syndromes · Dermatitis, Atopic · Bronchiolitis Obliterans Syndrome · Conjunctivitis, Allergic · Bronchiolitis Obliterans, led by 26 companies.
Drug pageCyclosporine: every studyMany companies study it; this page follows only the 81 they lead. All 388 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Novartis | 220 open or running | phase 4since Sep 6, 2005 | Sep 6, 2005 | none ahead |
| Pfizerits history only | 80 open or running | phase 4since Sep 13, 2005 | Jun 30, 2004 | none ahead |
| Hoffmann-La Rocheits history only | 70 open or running | phase 4since Jun 30, 2005 | Jun 30, 2005 | none ahead |
| Santen Pharmaceuticalits history only | 50 open or running | phase 3since May 19, 2006 | May 19, 2006 | none ahead |
| AbbVieits history only | 40 open or running | phase 4since Apr 22, 2014 | Apr 17, 2009 | none ahead |
| Zambon SpAits history only | 40 open or running | phase 3since Aug 30, 2018 | Aug 30, 2018 | none ahead |
| Sirion Therapeuticsits history only | 30 open or running | phase 3since Jul 13, 2007 | Jul 13, 2007 | none ahead |
| Amsterdam Molecular Therapeuticsits history only | 20 open or running | phase 3since Apr 30, 2009 | Apr 30, 2009 | none ahead |
| APT Pharmaceuticalsits history only | 20 open or running | phase 3since Sep 17, 2008 | Sep 17, 2008 | none ahead |
| Hanlim Pharm.its history only | 20 open or running | phase 3since Dec 10, 2012 | Dec 10, 2012 | none ahead |
| Innovative Medicalits history only | 20 open or running | phase 4since Jul 5, 2006 | Jul 5, 2006 | none ahead |
| Novaliqits history only | 20 open or running | phase 4since Mar 19, 2024 | Nov 25, 2015 | none ahead |
| Perle Bioscienceits history only | 20 open or running | phase 3since Jan 2, 2013 | Jan 2, 2013 | none ahead |
| Research Insightits history only | 20 open or running | phase 4since Apr 6, 2020 | Apr 6, 2020 | none ahead |
| Sigmoid Pharmaits history only | 20 open or running | phase 2since Dec 15, 2009 | Dec 15, 2009 | none ahead |
| Sun Pharmaceutical Industriesits history only | 20 open or running | phase 4since Apr 8, 2020 | Feb 13, 2016 | none ahead |
| Fovea Pharmaceuticalsits history only | 10 open or running | phase 2since Apr 29, 2010 | Apr 29, 2010 | none ahead |
| ISDINits history only | 10 open or running | phase 2since Dec 20, 2007 | Dec 20, 2007 | none ahead |
| LEO Pharmaits history only | 10 open or running | phase 4since Oct 16, 2018 | Oct 16, 2018 | none ahead |
| Pari Pharmaits history only | 10 open or running | phase 3since Apr 11, 2011 | Apr 11, 2011 | none ahead |
| PerioCits history only | 10 open or running | phase 2since Feb 12, 2015 | Feb 12, 2015 | none ahead |
| Pharming Groupits history only | 10 open or running | phase 1since Sep 11, 2012 | Sep 11, 2012 | none ahead |
| Spherium Biomedits history only | 10 open or running | phase 2since Aug 4, 2016 | Aug 4, 2016 | none ahead |
| Sublimity Therapeutics Holdcoits history only | 10 open or running | phase 2since Jan 31, 2019 | Jan 31, 2019 | none ahead |
| Takedaits history only | 10 open or running | phase 3since Nov 1, 1999 | Nov 1, 1999 | none ahead |
| Zhaoke (Guangzhou) Ophthalmology Pharmaceuticalits history only | 11 open or running | phase 3since Jan 3, 2025 | Jan 3, 2025 | none ahead |
Also a collaborator on its studies: Parexel, Dr. Falk Pharma, Syreon and The Clinical Trial.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Novartis only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 7 studies since Sep 6, 2005.
- Oct 3, 20052 phase 3 studies in Dermatitis, AtopicNCT00232076, NCT00232063
- Nov 30, 2005Phase 4 study in Hepatitis CNCT00260208 · 361 enrolled · United States, Switzerland
- May 30, 2006Phase 4 study in Liver TransplantationNCT00332462 · 34 enrolled · Germany
- Jan 8, 2007Phase 4 study in Kidney TransplantationNCT00419926 · 313 enrolled · Switzerland
- Feb 21, 2007Phase 3 study in Chronic Plaque PsoriasisNCT00438360 · 243 enrolled · Italy
- Jul 19, 2007Phase 2 study in Kidney TransplantationNCT00504543 · 311 enrolled · Argentina, Australia, Austria and more
- Jul 13, 2009Phase 4 study in Hepatitis CNCT00938860 · 92 enrolled · United States, Belgium, Brazil and more
- Jan 12, 2011Phase 3 study in Transplantation InfectionNCT01276457 · 223 enrolled
- Sep 29, 2011Phase 2 study in Renal TransplantationNCT01596062 · 16 enrolled · France
- Jan 26, 2012Phase 2 study in Dermatitis, AtopicNCT01552629 · 22 enrolled · Austria, France, Germany
- Apr 18, 2013Phase 3 study in Rejection, PsychologyNCT01843348 · 612 enrolled · France, Germany
- Feb 26, 2015Phase 2 study in Anemia, AplasticNCT02404025 · 10 enrolled · Japan
- Nov 4, 2016Phase 2 study in Anemia, AplasticNCT02998645 · 54 enrolled · Brazil, Hong Kong, India and more
- Mar 9, 2020Phase 2 study in Anemia, AplasticNCT04328727 · 36 enrolled · China, Japan, South Korea and more
TargetBeta
“Cyclophilin A modulator”ChEMBL 37, by rule
Studies
All 22 Novartis leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT04328727Anemia, Aplastic · China, Japan, South Korea and more | 2 | Completed | Jun 10, 2022 | 36 |
| NCT02998645Anemia, Aplastic · Brazil, Hong Kong, India and more | 2 | Completed | Nov 3, 2020 | 54 |
| NCT02404025Anemia, Aplastic · Japan | 2 | Completed | Jul 5, 2016 | 10 |
| NCT01843348Rejection, Psychology · France, Germany | 3 | Completed | Mar 23, 2016 | 612 |
| NCT01552629Dermatitis, Atopic · Austria, France, Germany | 2 | Completed | Aug 28, 2013 | 22 |
| NCT01596062Renal Transplantation · France | 2 | Completed | Mar 2013 | 16 |
| NCT01276457Transplantation Infection | 3 | Completed | Feb 2009 | 223 |
| NCT00938860Hepatitis C · United States, Belgium, Brazil and more | 4 | Completed | May 2013 | 92 |
| NCT00504543Kidney Transplantation · Argentina, Australia, Austria and more | 2 | Completed | Apr 2011 | 311 |
| NCT00438360Chronic Plaque Psoriasis · Italy | 3 | Completed | Nov 2007 | 243 |
| NCT00419926Kidney Transplantation · Switzerland | 4 | Completed | Jun 2009 | 313 |
| NCT00332462Liver Transplantation · Germany | 4 | Completed | Apr 2008 | 34 |
| NCT00260208Hepatitis C · United States, Switzerland | 4 | Terminated | Sep 2010 | 361 |
| NCT00232076Dermatitis, Atopic | 3 | Completed | Mar 2005 | |
| NCT00232063Dermatitis, Atopic | 3 | Completed | Nov 2005 | |
| NCT00171743Liver Transplant | 4 | Completed | Jan 2006 | 47 |
| NCT00171509Liver Transplant | 4 | Completed | Oct 2005 | 61 |
| NCT00171496Kidney Transplant | 4 | Completed | Mar 2006 | 693 |
| NCT00154284Organ Transplantation, Renal Transplantation | 3 | Completed | Jul 2008 | 114 |
| NCT00154193Heart and Lung Transplant · Switzerland | 4 | Completed | Nov 2007 | 190 |
| NCT00149994Liver Transplant · Switzerland | 4 | Completed | Dec 2007 | 171 |
| NCT00149890Infections · Germany | 3 | Completed | Mar 2009 | 77 |
How it is read
Names in the registry
- “cyclosporine”, 12 entries
- “Cyclosporine”, 10 entries
- “Cyclosporine A”, 6 entries
- “Ciclosporin”, 4 entries
- “Liposomal Cyclosporine A”, 3 entries
Codes read as this program: NOVA22007.
Conditions, from the studies’ own filings
- Dry Eye Syndromes, 15 studies
- Dermatitis, Atopic, 5 studies
- Bronchiolitis Obliterans Syndrome, 4 studies
- Conjunctivitis, Allergic, 4 studies
- Bronchiolitis Obliterans, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.